<DOC>
	<DOCNO>NCT02735993</DOCNO>
	<brief_summary>This cardiac registry study collect information patient ischemic non-ischemic heart failure treat adipose-derived regenerative cell ( ADRCs ) deliver via intramyocardial injection .</brief_summary>
	<brief_title>Cardiac REgistry Celution Device Processing Adipose-derived Regenerative Cells</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Males female &gt; 20 &lt; 80 year age Significant multivessel coronary artery disease amenable percutaneous surgical revascularization OR idiopathic dilate cardiomyopathy Symptoms heart failure ( e.g . NYHA Stages Heart Failure Class II III ) On maximal medical therapy heart failure present , anginal symptom Hemodynamic stability ( SBP ≥ 90 mm/Hg , HR &lt; 110 beats/min ) Ejection fraction ≤ 45 % Left ventricular wall thickness &gt; 5 mm target site ( ) cell injection , confirm Contrast Echo within 4 week prior enrollment , free thrombus Vascular anatomy and/or peripheral artery disease prevents impede cardiac catheterization Aortic mitral valve disease valve replacement indicate Presence mechanical aortic mitral valve Presence aortic dissection Planned stag treatment CAD therapeutic intervention heart within subsequent 3 month TIA stroke within 30 day prior procedure ICD placement ablation therapy within 30 day prior procedure Acute coronary syndrome ( ACS ) myocardial infarction 30 day prior procedure Revascularization within 30 day prior intramyocardial injection ADRCs Pregnant lactate status . Pregnancy determine positive pregnancy test screen baseline .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Celution</keyword>
	<keyword>ADRC</keyword>
	<keyword>Heart Failure</keyword>
	<keyword>Device</keyword>
</DOC>